EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudieOpen Access · CC BY-NC 4.0

Efficacy of a collagen matrix for soft tissue augmentation after implant placement compared to connective tissue grafts: A multicenter, noninferiority, randomized controlled trial

Christoph H F Hämmerle iD, Karin Jepsen, Irena Sailer iD, Malin Strasding iD, Marco Zeltner, Luca Cordaro iD, Vincenzo Mirisola di Torresanto, Frank Schwarz iD, Otto Zuhr, Dodji Akakpo, Franck Bonnet, Ignacio Sanz-Martín und 3 weitere

Clinical Oral Implants Research · 2023-09 · 34 (9) · 999-1013

DOI: 10.1111/clr.14127 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, online erschienen am 05.07.2023. Verfasst von Christoph H F Hämmerle und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Reconstructive Dentistry, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Dental Implants, Dental Implants, Single-Tooth. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Geistlich Pharma, Clinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Switzerland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To test whether soft tissue volume augmentation using a collagen matrix (VCMX) leads to noninferior results in terms of gain of mucosal thickness at single implant sites, compared to connective tissue grafts (SCTG).

Methods

The study was designed as a multi‐center randomized controlled clinical trial. Subjects in need of soft tissue volume augmentation at single tooth implant sites were consecutively recruited at nine centers. The deficient mucosal thickness at the implant sites (one per patient) was augmented by applying either a VCMX or a SCTG. Patients were examined at 120 days (abutment connection = primary endpoint), 180 days (final restoration), and 360 days (1‐year after insertion of the final restoration). Outcome measures included: transmucosal probing of the mucosal thickness (crestal = primary outcome), profilometric measurements of the tissue volume, and patient‐reported outcome measures (PROMs).

Results

Out of the 88 patients, 79 attended the one‐year follow‐up. The median increase of the crestal mucosal thickness between pre‐augmentation and 120 days was 0.3 ± 2.1 mm in the VCMX group and 0.8 ± 1.6 mm in the SCTG group ( p = .455). Non‐inferiority of the VCMX compared to the SCTG was not observed. The respective numbers at the buccal aspect amounted to 0.9 ± 2.0 mm (VCMX) and 1.1 ± 1.4 mm (SCTG; p = .431). PROMs including pain perception favored the VCMX group.

Conclusion

It remains inconclusive whether soft tissue augmentation using a VCMX is noninferior to SCTG in terms of crestal mucosal thickening at single implant sites. However, the use of collagen matrices favors PROMs especially pain perception, while achieving similar buccal volume gains along with comparable clinical and aesthetic parameters to SCTG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dental ImplantsDental Implants, Single-ToothHumansGingivaCollagenConnective TissueTreatment Outcome

Stichwörter der Autor:innen

collagen matrixdental implantsestheticspatient-reported outcomessoft tissue augmentationsubepithelial connective tissue grafttissue transplantation

Substanzen

Dental ImplantsCollagen

Autor:innen und Institutionen

  • Clinic of Reconstructive Dentistry, University of Zurich, Zurich, Switzerland.
  • Center for Dental and Oral Medicine, Department of Periodontology, Operative and Preventive Dentistry, University Hospital Bonn, Bonn, Germany.
  • Division of Fixed Prosthodontics and Biomaterials, University of Geneva, Geneva, Switzerland.
  • Private Practice Grimm Zahnaerzte, Horgen, Switzerland.
  • Department of Periodontology and Prosthodontics, Eastman Dental Hospital, University Policlinic Umberto I, Rome, Italy.
  • Department of Oral Surgery and Implantlogy, Carolinum Johan Wolfgang Goethe-University Frankfurt, Frankfurt, Germany.

ORCID-Profile: Christoph H F Hämmerle, Irena Sailer, Malin Strasding, Luca Cordaro, Frank Schwarz, Daniel S Thoma, Franz J Strauss

Förderung

  • Geistlich Pharma
  • Clinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Switzerland

Zitieren

APA

Hämmerle, C. H. F., Jepsen, K., Sailer, I., Strasding, M., Zeltner, M., Cordaro, L., Mirisola di Torresanto, V., Schwarz, F., Zuhr, O., Akakpo, D., Bonnet, F., Sanz-Martín, I., Thoma, D. S., Strauss, F. J., & Sanz, M. (2023). Efficacy of a collagen matrix for soft tissue augmentation after implant placement compared to connective tissue grafts: A multicenter, noninferiority, randomized controlled trial. Clinical Oral Implants Research, 34(9), 999-1013. https://doi.org/10.1111/clr.14127

Vancouver

Hämmerle CHF, Jepsen K, Sailer I, Strasding M, Zeltner M, Cordaro L, et al. Efficacy of a collagen matrix for soft tissue augmentation after implant placement compared to connective tissue grafts: A multicenter, noninferiority, randomized controlled trial. Clinical Oral Implants Research. 2023;34(9):999-1013. doi:10.1111/clr.14127

BibTeX
@article{Hmmerle2023,
  author = {Hämmerle, Christoph H F and Jepsen, Karin and Sailer, Irena and Strasding, Malin and Zeltner, Marco and Cordaro, Luca and Mirisola di Torresanto, Vincenzo and Schwarz, Frank and Zuhr, Otto and Akakpo, Dodji and Bonnet, Franck and Sanz-Martín, Ignacio and Thoma, Daniel S and Strauss, Franz J and Sanz, Mariano},
  title = {Efficacy of a collagen matrix for soft tissue augmentation after implant placement compared to connective tissue grafts: A multicenter, noninferiority, randomized controlled trial},
  journal = {Clinical Oral Implants Research},
  year = {2023},
  volume = {34},
  number = {9},
  pages = {999--1013},
  doi = {10.1111/clr.14127}
}
Kostenlos starten →